Trends in diabetic retinopathy and related medical practices among type 2 diabetes patients: Results from the National Insurance Service Survey 2006–2013

Journal of Diabetes Investigation

Volumn 9, Issue 1, 2018, Pages 173-178

  Song, Su Jeong ^a   Han, Kyungdo ^b   Choi, Kyung Seek ^c   Ko, Seung Hyun ^d   Rhee, Eun Jung ^a   Park, Cheol Young ^a   Park, Joong Yeol ^e   Lee, Ki Up ^e   Ko, Kyung Soo ^f  

^a School of Medicine   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

^c Soonchunhyang University College of Medicine   (South Korea)

^d The Catholic University of Korea   (South Korea)

^e University of Ulsan College of Medicine   (South Korea)

^f Inje University College of Medicine   (South Korea)

Author keywords

Diabetic retinopathy; Epidemiology; Insurance

Indexed keywords

ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIAGNOSTIC PROCEDURE; EYE EXAMINATION; FEMALE; FOLLOW UP; GROUPS BY AGE; HEALTH SURVEY; HUMAN; INCIDENCE; KOREAN (PEOPLE); LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MIDDLE AGED; NATIONAL HEALTH INSURANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; SCREENING TEST; SEX DIFFERENCE; TREND STUDY; VERY ELDERLY; VISUAL IMPAIRMENT; VITRECTOMY; ASIAN CONTINENTAL ANCESTRY GROUP; COMPLICATION; QUESTIONNAIRE; SOUTH KOREA;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES;

EID: 85020753071     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12655     Document Type: Article

References (22)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4–14.
2. Keeffe J, Taylor HR, Fotis K, et al. Prevalence and causes of vision loss in Southeast Asia and Oceania: 1990-2010. Br J Ophthalmol 2014; 98: 586–591.
3. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82: 844–851.
4. Lin JC, Shau WY, Lai MS. Sex- and age-specific prevalence and incidence rates of sight-threatening diabetic retinopathy in Taiwan. JAMA Ophthalmol 2014; 132: 922–928.
5. Klein R, Klein BE. Are individuals with diabetes seeing better?: a long-term epidemiological perspective. Diabetes 2010; 59: 1853–1860.
6. Hovind P, Tarnow L, Rossing K, et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 2003; 26: 1258–1264.
7. Klein R, Knudtson MD, Lee KE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 2008; 115: 1859–1868.
8. Onakpoya OH, Kolawole BA, Adeoye AO, et al. Visual impairment and blindness in type 2 diabetics: Ife-Ijesa diabetic retinopathy study. Int Ophthalmol 2016; 36: 477–485.
9. Park SJ, Choi NK, Park KH, et al. Nationwide incidence of clinically diagnosed retinal vein occlusion in Korea, 2008 through 2011: preponderance of women and the impact of aging. Ophthalmology 2014; 121: 1274–1280.
10. Park SJ, Kwon KE, Choi NK, et al. Prevalence and Incidence of Exudative Age-Related Macular Degeneration in South Korea: a Nationwide Population-Based Study. Ophthalmology 2015; 122: e1.
11. Lee YH, Han K, Ko SH, et al. Data Analytic Process of a Nationwide Population-Based Study Using National Health Information Database Established by National Health Insurance Service. Diabetes Metab J 2016; 40: 79–82.
12. Park CY, Park SE, Bae JC, et al. Prevalence of and risk factors for diabetic retinopathy in Koreans with type II diabetes: baseline characteristics of Seoul Metropolitan City-Diabetes Prevention Program (SMC-DPP) participants. Br J Ophthalmol 2012; 96: 151–155.
13. Wong TY, Cheung N, Tay WT, et al. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology 2008; 115: 1869–1875.
14. Xu J, Wei WB, Yuan MX, et al. Prevalence and risk factors for diabetic retinopathy: the Beijing Communities Diabetes Study 6. Retina 2012; 32: 322–329.
15. Cai X, Han X, Zhang S, et al. Age at diagnosis and C-peptide level are associated with diabetic retinopathy in Chinese. PLoS One 2014; 9: e91174.
16. Ozawa GY, Bearse MA Jr, Adams AJ. Male-female differences in diabetic retinopathy? Curr Eye Res 2015; 40: 234–246.
17. Klein R, Lee KE, Gangnon RE, et al. The 25-year incidence of visual impairment in type 1 diabetes mellitus the wisconsin epidemiologic study of diabetic retinopathy. Ophthalmology 2010; 117: 63–70.
18. Sloan FA, Yashkin AP, Chen Y. Gaps in receipt of regular eye examinations among medicare beneficiaries diagnosed with diabetes or chronic eye diseases. Ophthalmology 2014; 121: 2452–2460.
19. Wang D, Ding X, He M, et al. Use of eye care services among diabetic patients in urban and rural China. Ophthalmology 2010; 117: 1755–1762.
20. Bressler NM, Varma R, Doan QV, et al. Underuse of the health care system by persons with diabetes mellitus and diabetic macular edema in the United States. JAMA Ophthalmol 2014; 132: 168–173.
21. Klein R, Lee KE, Knudtson MD, et al. Changes in visual impairment prevalence by period of diagnosis of diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 2009; 116: 1937–1942.
22. Centers for Disease Control and Prevention(CDC). Self-reported visual impairment among persons with diagnosed diabetes — United States, 1997–2010. MMWR Morb Mortal Wkly Rep 2011; 60: 1549–1553.